Clever Leaves and Ethypharm Announce German Pharmaceutical Cannabis Partnership
NEW YORK, March 17, 2021 (GLOBE NEWSWIRE)
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) ( Clever Leaves or the Company ), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, today announced the signing of a supply agreement with Ethypharm ( Ethypharm ), a European manufacturer and distributor of pharmaceutical products, for the sale of medical cannabis extracts produced in Clever Leaves EU-GMP certified facilities in Colombia. The initial portfolio of products includes high-CBD, high-THC, and balanced CBD and THC formulations developed exclusively by Clever Leaves to meet the regulatory needs of the German market.